|
|||||
|
|

Bedding manufacturer Somnigroup (NYSE:SGI) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 54.7% year on year to $1.87 billion. Its non-GAAP profit of $0.72 per share was in line with analysts’ consensus estimates.
Is now the time to buy SGI? Find out in our full research report (it’s free for active Edge members).
Somnigroup’s fourth quarter results drew a negative market response, as revenue fell short of Wall Street’s consensus despite a substantial year-over-year increase. Management pointed to persistent softness in the bedding industry, which they said experienced mid-single-digit declines in the U.S. and similar pressures internationally. CEO Scott Thompson described the period as "another challenging year for the bedding industry," noting that even with Somnigroup’s share gains, overall market demand lagged expectations. The integration of Mattress Firm was highlighted as a key achievement, accelerating scale and cost benefits, but management acknowledged that broader market weakness impacted both direct and wholesale channels.
Looking to 2026, management’s guidance reflects a cautious stance, driven by expectations for only slight improvement in global bedding demand. CEO Scott Thompson explained that guidance assumes a "flat market," with any upside dependent on a stronger-than-anticipated industry rebound. The company’s outlook is anchored by planned operational efficiencies, continued synergies from the Mattress Firm combination, and expanded advertising investments. CFO Bhaskar Rao cautioned that commodity headwinds and ongoing integration costs could weigh on margins, stating, “The foundation being industry, market share gains, and margin expansion, it gets you to in or around the midpoint.”
Management attributed the quarter’s performance to resilience in core brands, synergy realization from acquisitions, and marketing investments, while acknowledging industry-wide demand softness and operational challenges.
Management expects industry normalization, synergy realization, and continued brand investments to drive gradual improvement, but acknowledges persistent headwinds may limit near-term upside.
In the upcoming quarters, the StockStory team will monitor (1) the pace at which Somnigroup realizes additional cost and sales synergies from the Mattress Firm integration, (2) the impact of upcoming product launches, particularly for Stearns & Foster, on sales momentum, and (3) whether industry demand shows signs of recovery or remains flat. Additionally, we will watch Somnigroup’s progress in expanding international distribution and managing cost pressures.
Somnigroup currently trades at $88.26, down from $96.04 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
| 9 hours | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-15 | |
| Feb-11 | |
| Feb-10 | |
| Feb-10 | |
| Feb-09 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite